Seelos Therapeutics Inc SEEL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:41 PM EDT
0.60quote price arrow down-0.0393 (-6.1473%)
Volume
416,739
52 week range
0.37 - 49.80
Loading...
  • Open0.65
  • Day High0.68
  • Day Low0.572
  • Prev Close0.6393
  • 52 Week High49.80
  • 52 Week High Date08/03/23
  • 52 Week Low0.37
  • 52 Week Low Date03/19/24

Key Stats

  • Market Cap8.208M
  • Shares Out13.68M
  • 10 Day Average Volume0.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.89
  • YTD % Change-56.83

KEY STATS

  • Open0.65
  • Day High0.68
  • Day Low0.572
  • Prev Close0.6393
  • 52 Week High49.80
  • 52 Week High Date08/03/23
  • 52 Week Low0.37
  • 52 Week Low Date03/19/24
  • Market Cap8.208M
  • Shares Out13.68M
  • 10 Day Average Volume0.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.89
  • YTD % Change-56.83

RATIOS/PROFITABILITY

  • EPS (TTM)-8.95
  • P/E (TTM)-0.07
  • Fwd P/E (NTM)-0.13
  • EBITDA (TTM)-40.499M
  • ROE (TTM)-584.20%
  • Revenue (TTM)2.203M
  • Gross Margin (TTM)79.21%
  • Net Margin (TTM)-1,719.56%
  • Debt To Equity (MRQ)-42.41%

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Seelos Therapeutics Inc

 

Profile

MORE
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The Company operates under one segment which develops pharmaceutical products. The Company's programs include SLS-002 for the potential treatment of acute suicidal ideation and behavior (ASIB) in patients with major depressive disorder (MDD) and...
Raj Mehra J.D., Ph.D.
Chairman of the Board, President, Chief Executive Officer
Michael Golembiewski
Chief Financial Officer
Address
300 PARK AVENUE, 2ND FLOOR
New York, NY
10022
United States

Top Peers

SYMBOLLASTCHG%CHG
TLPH
Talphera Inc
1.04-0.06-5.50%
KALA
KALA BIO Inc
7.98+0.13+1.62%
TRVN
Trevena Inc
0.4657+0.0071+1.5482%
AVTX
Avalo Therapeutics Inc
30.35+25.60+538.95%
VYNE
Vyne Therapeutics Inc
3.06+0.10+3.38%